Strikingly, high levels of α6-integrin, FOSL1 and αV-integrin expression were all correlated with significantly reduced survival of both in pancreatic cancer and lung cancer patients when compared with patients with low level expression of the same genes (Figure 8). The gene discussed is FOSL1; the disease is pancreatic neoplasm.